Virax Biolabs Group Ltd (ticker: VRAX) is an NASDAQ-listed in vitro & in vivo diagnostic substances company. DredgeCap's structured extraction of VRAX's SEC filings surfaces 3 active risk signals, including 2 late-filing signals, and 1 auditor-change signal. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
VRAX SEC Filings
Full cached SEC EDGAR filing history for VRAX, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.